Whizai Closes New Round With Investment From Shanda Group And Amerisourcebergen Bringing Total Capital Raised To $21 Million

Oct 25, 2022•about 3 years ago

SomersetBioinformaticsLife ScienceMachine LearningArtificial IntelligenceBiotechnologyHealth CareSoftwareAnalytics

Description

WhizAI, the first and only augmented analytics platform purpose built for the life sciences and healthcare industries, has announced it has completed a new round of funding bringing total funding since launching in 2017 to $21 million. The company received investment from strategic investors Shanda Group and AmerisourceBergen’s AB Health Ventures, with participation from existing investors like Vertical Venture Partners and Healthy Ventures.

Company Information

Company

WhizAI

Location

Somerset, Pennsylvania, United States

About

WhizAI is the first and only AI-powered analytics platform purpose-built for life sciences. It puts insights directly into the hands of business users empowering decision-makers to drive more informed and faster business decisions at lower cost. With its deep understanding of the life sciences domain and user intent, the platform delivers insights without the delays of traditional BI dashboards. Fast, easy, and scalable, WhizAI is transforming analytics with artificial intelligence optimized for life sciences making WhizAI the trusted partner of choice at top global life sciences companies.

Related People

2 contacts

Whizai Closes New Round With Investment From Shanda Group And Amerisourcebergen Bringing Total Capital Raised To $21 Million

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Company Information